标题
Oncogenic functions and therapeutic targeting of EphA2 in cancer
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-03-08
DOI
10.1038/s41388-021-01714-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Ephrin Receptor Tyrosine kinase A2 with a selective aptamer for glioblastoma stem cells
- (2020) Alessandra Affinito et al. Molecular Therapy-Nucleic Acids
- MMAE delivery using the Bicycle toxin conjugate BT5528
- (2020) Gavin Bennett et al. MOLECULAR CANCER THERAPEUTICS
- Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level
- (2020) Jing Mo et al. CELLULAR ONCOLOGY
- Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC
- (2020) Caroline Volz et al. Cell Reports
- Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex
- (2020) Laurent Fattet et al. DEVELOPMENTAL CELL
- Phosphorylation of PLCγ1 by EphA2 receptor tyrosine kinase promotes tumor growth in lung cancer
- (2020) Wenqiang Song et al. MOLECULAR CANCER RESEARCH
- Eph receptor signalling: from catalytic to non-catalytic functions
- (2019) Lung-Yu Liang et al. ONCOGENE
- EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma
- (2019) Yi-Hung Carol Tan et al. Oncogenesis
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors
- (2019) Kohei Shitara et al. Journal for ImmunoTherapy of Cancer
- MA09.01 A Phase I/II Trial of Dasatinib and Osimertinib in TKI Naïve Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
- (2019) C. Kim et al. Journal of Thoracic Oncology
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
- (2019) Alessandra Affinito et al. Molecular Therapy-Nucleic Acids
- An Agonistic Antibody to EPHA2 Exhibits Antitumor Effects on Human Melanoma Cells
- (2018) ATSUSHI SAKAMOTO et al. ANTICANCER RESEARCH
- Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell
- (2018) Luca Gambini et al. ACS Chemical Biology
- Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
- (2017) Kevin Bielamowicz et al. NEURO-ONCOLOGY
- Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
- (2017) W Song et al. ONCOGENE
- Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
- (2017) Alireza Azimi et al. Cell Death & Disease
- Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs
- (2016) Stephanie Heinzlmeir et al. ACS Chemical Biology
- Novel anti-EPHA2 antibody, DS-8895a for cancer treatment
- (2016) Jun Hasegawa et al. CANCER BIOLOGY & THERAPY
- EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer
- (2016) Katherine R. Amato et al. CANCER RESEARCH
- The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer
- (2016) Victoria M. Youngblood et al. CANCER RESEARCH
- EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation
- (2016) Yuho Hamaoka et al. CELLULAR SIGNALLING
- TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis
- (2016) Z. Mitri et al. CLINICAL CANCER RESEARCH
- Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study
- (2016) Ian F. Pollack et al. JOURNAL OF NEURO-ONCOLOGY
- Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
- (2016) Antonio Barquilla et al. MOLECULAR BIOLOGY OF THE CELL
- The Adult Ventricular–Subventricular Zone (V-SVZ) and Olfactory Bulb (OB) Neurogenesis
- (2016) Daniel A. Lim et al. Cold Spring Harbor Perspectives in Biology
- Simultaneous targeting of Eph receptors in glioblastoma
- (2016) Sara Ferluga et al. Oncotarget
- Proteolysis of EphA2 Converts It from a Tumor Suppressor to an Oncoprotein
- (2015) N. Koshikawa et al. CANCER RESEARCH
- Eph receptor tyrosine kinases in cancer stem cells
- (2015) Jin Chen et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Chemical Proteomics Uncovers EPHA2 as a Mechanism of Acquired Resistance to Small Molecule EGFR Kinase Inhibition
- (2015) Heiner Koch et al. JOURNAL OF PROTEOME RESEARCH
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenicKRasin promoting lung adenocarcinoma
- (2015) Narayana Yeddula et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2
- (2015) Yue Zhou et al. Nature Communications
- JNK Signaling Mediates EPHA2-Dependent Tumor Cell Proliferation, Motility, and Cancer Stem Cell-like Properties in Non-Small Cell Lung Cancer
- (2014) W. Song et al. CANCER RESEARCH
- Prognostic role of EphA2 in various human carcinomas: a meta-analysis of 23 related studies
- (2014) Weisong Shen et al. GROWTH FACTORS
- Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC
- (2014) Katherine R. Amato et al. JOURNAL OF CLINICAL INVESTIGATION
- EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties
- (2014) H Miao et al. ONCOGENE
- EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
- (2014) B. Miao et al. Cancer Discovery
- Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy-Mediated Metastatic Melanoma Phenotype
- (2014) K. H. T. Paraiso et al. Cancer Discovery
- Eph receptor and ephrin function in breast, gut, and skin epithelia
- (2014) Bethany E Perez White et al. Cell Adhesion & Migration
- EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion
- (2013) Nami Sugiyama et al. JOURNAL OF CELL BIOLOGY
- Prognostic Significance of Combinations of RNA-Dependent Protein Kinase and EphA2 Biomarkers for NSCLC
- (2013) Chengcheng Guo et al. Journal of Thoracic Oncology
- Phase II Study of Dasatinib (BMS-354825) in Patients With Metastatic Adenocarcinoma of the Pancreas
- (2013) C. E. Chee et al. ONCOLOGIST
- Eph Receptor Signaling and Ephrins
- (2013) E. M. Lisabeth et al. Cold Spring Harbor Perspectives in Biology
- Roles of EphA2 in Development and Disease
- (2013) Jeong Park et al. Genes
- The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas
- (2012) Elena Binda et al. CANCER CELL
- 'Til Eph Do Us Part': Intercellular Signaling via Eph Receptors and Ephrin Ligands Guides Cerebral Cortical Development from Birth Through Maturation
- (2012) H. A. North et al. CEREBRAL CORTEX
- Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors
- (2012) Christina M. Annunziata et al. INVESTIGATIONAL NEW DRUGS
- Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma
- (2012) Masashi Ishikawa et al. LUNG CANCER
- T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
- (2012) Kevin KH Chow et al. MOLECULAR THERAPY
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study
- (2011) R. S. Finn et al. CLINICAL CANCER RESEARCH
- Epha2 is a critical oncogene in melanoma
- (2011) D Udayakumar et al. ONCOGENE
- Eph/Ephrin Profiling in Human Breast Cancer Reveals Significant Associations between Expression Level and Clinical Outcome
- (2011) Dana M. Brantley-Sieders et al. PLoS One
- Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer
- (2010) Yesim Gökmen-Polar et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase 2 trial of dasatinib in advanced melanoma
- (2010) Harriet M. Kluger et al. CANCER
- EphA2 as a promoter of melanoma tumorigenicity
- (2010) Naira V. Margaryan et al. CANCER BIOLOGY & THERAPY
- EphA2Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation
- (2010) Leonardo Faoro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histological types of breast cancer: How special are they?
- (2010) Britta Weigelt et al. Molecular Oncology
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
- (2009) Hui Miao et al. CANCER CELL
- EphA2 in the Early Pathogenesis and Progression of Non-Small Cell Lung Cancer
- (2009) J. M. Brannan et al. Cancer Prevention Research
- EphA2 Reexpression Prompts Invasion of Melanoma Cells Shifting from Mesenchymal to Amoeboid-like Motility Style
- (2009) M. Parri et al. CANCER RESEARCH
- Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
- (2009) G. Zhuang et al. CANCER RESEARCH
- Cell adhesion and EGFR activation regulate EphA2 expression in cancer
- (2009) Alice Bjerregaard Larsen et al. CELLULAR SIGNALLING
- Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex
- (2009) Juha P Himanen et al. EMBO REPORTS
- Regulation of Mammary Gland Branching Morphogenesis by EphA2 Receptor Tyrosine Kinase
- (2009) David Vaught et al. MOLECULAR BIOLOGY OF THE CELL
- EphA2 Is an Essential Mediator of UV Radiation-Induced Apoptosis
- (2008) G. Zhang et al. CANCER RESEARCH
- A Human Antibody-Drug Conjugate Targeting EphA2 Inhibits Tumor Growth In vivo
- (2008) D. Jackson et al. CANCER RESEARCH
- The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
- (2008) Dana M. Brantley-Sieders et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas
- (2008) Hideho Okada et al. JOURNAL OF NEURO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now